Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patients

Cancer Immunology, Immunotherapy

Volumn 58, Issue 1, 2009, Pages 145-151

  Jacobs, Joannes F M ^a   Aarntzen, Erik H J G ^a   Sibelt, Lenny A G ^a   Blokx, Willeke A ^a   Boullart, Anna C I ^a   Gerritsen, Marie Jeanne ^a   Hoogerbrugge, Peter M ^a   Figdor, Carl G ^b   Adema, Gosse J ^b   Punt, Cornelis J A ^a   De Vries, I Jolanda M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Melanoma; Melanoma differentiation antigen; T cells; Vitiligo

Indexed keywords

DENDRITIC CELL VACCINE; GAMMA INTERFERON; GLYCOPROTEIN GP 100; INTERLEUKIN 2; MELANOMA ANTIGEN; MELANOMA DIFFERENTIATION ANTIGEN; MONOPHENOL MONOOXYGENASE; TETRAMER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CASE REPORT; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MALE; MELANOMA; PRIORITY JOURNAL; RASH; SKIN METASTASIS; VITILIGO;

AGED; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOTHERAPY; INTERFERON-GAMMA; MALE; MELANOMA; MIDDLE AGED; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VITILIGO; YOUNG ADULT;

EID: 54849412580     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-008-0506-5     Document Type: Article

References (31)

1. V Appay C Jandus V Voelter S Reynard SE Coupland D Rimoldi D Lienard P Guillaume AM Krieg JC Cerottini P Romero S Leyvraz N Rufer DE Speiser 2006 New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site J Immunol 177 1670
2. J Banchereau AK Palucka M Dhodapkar S Burkeholder N Taquet A Rolland S Taquet S Coquery KM Wittkowski N Bhardwaj L Pineiro R Steinman J Fay 2001 Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine Cancer Res 61 6451
3. T Boon PG Coulie B Van den Eynde 1997 Tumor antigens recognized by T cells Immunol Today 18 267
4. PK Das RM van den Wijngaard A Wankowicz-Kalinska IC Le Poole 2001 A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo Trends Immunol 22 130
5. IJ de Vries MR Bernsen WJ Lesterhuis NM Scharenborg SP Strijk MJ Gerritsen DJ Ruiter CG Figdor CJ Punt GJ Adema 2005 Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome J Clin Oncol 23 5779
6. TJ de Vries M Smeets R de Graaf K Hou-Jensen EB Brocker N Renard AM Eggermont GN van Muijen DJ Ruiter 2001 Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group J Pathol 193 13
7. VH Engelhard TN Bullock TA Colella SL Sheasley DW Mullins 2002 Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy Immunol Rev 188 136
8. S Ferrone FM Marincola 1995 Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance Immunol Today 16 487
9. S Garbelli S Mantovani B Palermo C Giachino 2005 Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity? Pigment Cell Res 18 234
10. KM Lally S Mocellin GA Ohnmacht MB Nielsen M Bettinotti MC Panelli V Monsurro FM Marincola 2001 Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading Int J Cancer 93 841
11. KS Lang CC Caroli A Muhm D Wernet A Moris B Schittek E Knauss-Scherwitz S Stevanovic HG Rammensee C Garbe 2001 HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1 J Invest Dermatol 116 891
12. IC Le Poole RM van den Wijngaard W Westerhof RP Dutrieux PK Das 1993 Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation J Invest Dermatol 100 816
13. R Lengagne FA Le Gal M Garcette L Fiette P Ave M Kato JP Briand C Massot I Nakashima L Renia JG Guillet A Prevost-Blondel 2004 Spontaneous vitiligo in an animal model for human melanoma: role of tumor-specific CD8+ T cells Cancer Res 64 1496
14. C Lurquin B Lethe E De Plaen V Corbiere I Theate N van Baren PG Coulie T Boon 2005 Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen J Exp Med 201 249
15. A Mackensen B Herbst JL Chen G Kohler C Noppen W Herr GC Spagnoli V Cerundolo A Lindemann 2000 Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells Int J Cancer 86 385
16. RL Mandelcorn-Monson NH Shear E Yau S Sambhara BH Barber D Spaner MA DeBenedette 2003 Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients J Invest Dermatol 121 550
17. K Ongenae N Van Geel JM Naeyaert 2003 Evidence for an autoimmune pathogenesis of vitiligo Pigment Cell Res 16 90
18. WW Overwijk MR Theoret SE Finkelstein DR Surman LA de Jong FA Vyth-Dreese TA Dellemijn PA Antony PJ Spiess DC Palmer DM Heimann CA Klebanoff Z Yu LN Hwang L Feigenbaum AM Kruisbeek SA Rosenberg NP Restifo 2003 Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells J Exp Med 198 569
19. B Palermo R Campanelli S Garbelli S Mantovani E Lantelme V Brazzelli M Ardigo G Borroni M Martinetti C Badulli A Necker C Giachino 2001 Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo J Invest Dermatol 117 326
20. B Palermo S Garbelli S Mantovani E Scoccia GA Da Prada P Bernabei MA Avanzini V Brazzelli G Borroni C Giachino 2005 Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo Eur J Immunol 35 3153
21. GQ Phan E Wang FM Marincola 2001 T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance Expert Opin Biol Ther 1 511
22. KU Schallreuter C Levenig J Berger 1991 Vitiligo and cutaneous melanoma. A case study Dermatologica 183 239
23. CL Slingluff Jr TA Colella L Thompson DD Graham JC Skipper J Caldwell L Brinckerhoff DJ Kittlesen DH Deacon C Oei NL Harthun EL Huczko DF Hunt TL Darrow VH Engelhard 2000 Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens Cancer Immunol Immunother 48 661
24. H Tsao P Millman GP Linette FS Hodi AJ Sober MA Goldberg FG Haluska 2002 Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic cell vaccine for metastatic melanoma Arch Dermatol 138 799
25. H Uchi R Stan MJ Turk ME Engelhorn GA Rizzuto SM Goldberg JD Wolchok AN Houghton 2006 Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo Adv Immunol 90 215
26. R van den Wijngaard A Wankowicz-Kalinska C Le Poole B Tigges W Westerhof P Das 2000 Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site Lab Invest 80 1299
27. M Viguier F Lemaitre O Verola MS Cho G Gorochov L Dubertret H Bachelez P Kourilsky L Ferradini 2004 Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells J Immunol 173 1444
28. S Wang S Bartido G Yang J Qin Y Moroi KS Panageas JJ Lewis AN Houghton 1999 A role for a melanosome transport signal in accessing the MHC class II presentation pathway and in eliciting CD4+ T cell responses J Immunol 163 5820
29. A Wankowicz-Kalinska C Le Poole R van den Wijngaard WJ Storkus PK Das 2003 Melanocyte-specific immune response in melanoma and vitiligo: two faces of the same coin? Pigment Cell Res 16 254
30. A Wankowicz-Kalinska RM van den Wijngaard BJ Tigges W Westerhof GS Ogg V Cerundolo WJ Storkus PK Das 2003 Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo Lab Invest 83 683
31. HM Zarour JM Kirkwood LS Kierstead W Herr V Brusic CL Slingluff Jr J Sidney A Sette WJ Storkus 2000 Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells Proc Natl Acad Sci USA 97 400